Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort.


Journal

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 16 09 2019
revised: 24 12 2019
accepted: 29 12 2019
pubmed: 14 1 2020
medline: 3 7 2021
entrez: 14 1 2020
Statut: ppublish

Résumé

To identify factors associated with unfavourable in-hospital outcome (death or disability) in adults with community-acquired bacterial meningitis (CABM). In a prospective multicentre cohort study (COMBAT; February 2013 to July 2015), all consecutive cases of CABM in the 69 participating centres in France were enrolled and followed up for 12 months. Factors associated with unfavourable outcome were identified by logistic regression and long-term disability was analysed. Among the 533 individuals enrolled, (Streptococcus pneumoniae 53.8% (280/520 isolates identified), Neisseria meningitidis 21.3% (111/520), others 24.9% (129/520)), case fatality rate was 16.9% (90/533) and unfavourable outcome occurred in 45.0% (225/500). Factors independently associated with unfavourable outcome were: age >70 years (adjusted odds ratio (aOR) 4.64; 95% CI 1.93-11.15), male gender (aOR 2.11; 95% CI 1.25-3.57), chronic renal failure (aOR 6.65; 95% CI 1.57-28.12), purpura fulminans (aOR 4.37; 95% CI 1.38-13.81), localized neurological signs (aOR 3.72; 95% CI 2.29-6.05), disseminated intravascular coagulation (aOR 3.19; 95% CI 1.16-8.79), cerebrospinal fluid (CSF) white-cell count <1500 cells/μL (aOR 2.40; 95% CI 1.42-4.03), CSF glucose concentration (0.1-2.5 g/L: aOR 1.92; 95% CI 1.01-3.67; <0.1 g/L: aOR 2.24; 95% CI 1.01-4.97), elevated CSF protein concentration (aOR 1.09; 95% CI 1.03-1.17), time interval between hospitalization and lumbar puncture >1 day (aOR 2.94; 95% CI 1.32-6.54), and S. pneumoniae meningitis (aOR 4.99; 95% CI 1.98-12.56), or meningitis other than N. meningitidis (aOR 4.54; 95% CI 1.68-12.27). At 12 months, 26.7% (74/277) had hearing loss, 32.8% (87/265) depressive symptoms, 31.0% (86/277) persistent headache, and 53.4% had a physical health-related quality of life (142/266) <25th centile of the distribution of the score in the general French population (p < 0.0001). The burden of CABM (death, disability, depression, impaired quality of life and hearing loss) is high. Identification of cases from the first symptoms may improve prognosis. Gov identification number: NCT01730690.

Identifiants

pubmed: 31927117
pii: S1198-743X(19)30679-2
doi: 10.1016/j.cmi.2019.12.020
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Banques de données

ClinicalTrials.gov
['NCT01730690']

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1192-1200

Investigateurs

Xavier Duval (X)
Bruno Hoen (B)
Bruno Mourvillier (B)
Marie-Cécile Ploy (MC)
Sarah Tubiana (S)
Emmanuelle Varon (E)
François Caron (F)
Pierre-Edouard Bollaert (PE)
Olivier Gaillot (O)
Muhamed-Kheir Taha (MK)
Claire Poyart (C)
Stephane Bonacorsi (S)
François Vandenesch (F)
Emmanuelle Cambau (E)
Marc Lecuit (M)
Alain Gravet (A)
Bruno Frachet (B)
Thomas De Broucker (T)
Daniel Levy Bruhl (D)
François Raffi (F)
Nadia Anguel (N)
Laurent Argaud (L)
Sophie Arista (S)
Laurence Armand-Lefevre (L)
Stéphanie Balavoine (S)
Régine Baraduc (R)
Guilène Barnaud (G)
Guillaume Beraud (G)
Louis Bernard (L)
Georges Bernars (G)
Dominique Bertei (D)
Emilie Bessede (E)
Typhaine Billard Pomares (T)
Charlotte Biron (C)
Stéphane Bland (S)
Julien Boileau (J)
Patrice Boubeau (P)
Sandra Bourdon (S)
Aurore Bousquet (A)
Sophie Boyer (S)
Alexis Bozorg-Grayeli (A)
Laurent Bret (L)
Cédric Bretonniere (C)
François Bricaire (F)
Elsa Brocas (E)
Michel Brun (M)
Jennifer Buret (J)
Christophe Burucoa (C)
Jean Cabalion (J)
Mathieu Cabon (M)
Emmanuelle Cambau (E)
Guillaume Camuset (G)
Christophe Canevet (C)
François Caron (F)
Anne Carricajo (A)
Bernard Castan (B)
Eric Caumes (E)
Charles Cazanave (C)
Amélie Chabrol (A)
Thibaut Challan-Belval (T)
Vanessa Chanteperdrix-Marillier (V)
Chantal Chaplain (C)
Caroline Charlier-Woerther (C)
Hélène Chaussade (H)
Catherine Chirouze (C)
Bernard Clair (B)
Julien Colot (J)
Jean-Marie Conil (JM)
Hugues Cordel (H)
Philippe Cormier (P)
Joël Cousson (J)
Pierrick Cronier (P)
Eric Cua (E)
Anne Dao-Dubremetz (A)
Sylvie Dargere (S)
Nicolas Degand (N)
Sophie Dekeyser (S)
Deborah Delaune (D)
Eric Denes (E)
Pierre-Francois Dequin (PF)
Diane Descamps (D)
Elodie Descloux (E)
Jean-Luc Desmaretz (JL)
Jean-Luc Diehl (JL)
Jérôme Dimet (J)
Aurélien Dinh (A)
Xavier Duval (X)
Lelia Escaut (L)
Claude Fabe (C)
Frédéric Faibis (F)
Clara Flateau (C)
Nathalie Fonsale (N)
Emmanuel Forestier (E)
Nicolas Fortineau (N)
Amandine Gagneux-Brunon (A)
None Garandeau
Magali Garcia (M)
Denis Garot (D)
Stéphane Gaudry (S)
François Goehringer (F)
Alain Gravet (A)
Valérie Gregoire-Faucher (V)
Marine Grosset (M)
Camélia Gubavu (C)
Isabelle Gueit (I)
Dominique Guelon (D)
Thomas Guimard (T)
Jérôme Guinard (J)
Tahar Hadou (T)
Jean-Pierre Helene (JP)
Sandrine Henard (S)
Benoit Henry (B)
Anne-Cécile Hochart (AC)
Bruno Hoen (B)
Gabriela Illes (G)
Sylvain Jaffuel (S)
Irène Jarrin (I)
Françoise Jaureguy (F)
Cédric Joseph (C)
Marie-Emmanuelle Juvin (ME)
Samer Kayal (S)
Flore Lacassin (F)
Isabelle Lamaury (I)
Philippe Lanotte (P)
Etienne Laurens (E)
Henri Laurichesse (H)
Cécile Le Brun (C)
Vincent Le Moing (V)
Paul Le Turnier (P)
Hervé Lecuyer (H)
Sylvie Ledru (S)
Céline Legrix (C)
Adrien Lemaignen (A)
Chantal Lemble (C)
Ludovic Lemee (L)
Olivier Lesens (O)
Marion Levast (M)
Claire Lhommet (C)
Silvija Males (S)
Edith Malpote (E)
Guillaume Martin-Blondel (G)
Matthieu Marx (M)
Raphael Masson (R)
Olivier Matray (O)
Aurore Mbadi (A)
Frédéric Mechai (F)
Guillaume Mellon (G)
Audrey Merens (A)
Marie Caroline Meyohas (MC)
Adrien Michon (A)
Joy Mootien Yoganaden (J)
David Morquin (D)
Stéphane Mouly (S)
Natacha Mrozek (N)
Sophie Nguyen (S)
Yohan Nguyen (Y)
Maja Ogielska (M)
Eric Oziol (E)
Bernard Page (B)
Solène Patrat-Delon (S)
Isabelle Patry (I)
André Pechinot (A)
Sandrine Picot (S)
None Pierrejean
Lionel Piroth (L)
Claire Plassart (C)
Patrice Plessis (P)
Marie-Cécile Ploy (MC)
Laurent Portel (L)
Patrice Poubeau (P)
Marie Poupard (M)
Claire Poyart (C)
Thierry Prazuck (T)
Luc Quaesaet (L)
François Raffi (F)
Adriatsiferana Ramanantsoa (A)
Christophe Rapp (C)
Laurent Raskine (L)
Josette Raymond (J)
Matthieu Revest (M)
Agnès Riche (A)
Stéphanie Robaday-Voisin (S)
Frédéric Robin (F)
Jean-Pierre Romaszko (JP)
Florence Rousseau (F)
Anne-Laure Roux (AL)
Cecile Royer (C)
Matthieu Saada (M)
Dominique Salmon (D)
Carlo Saroufim (C)
Jean-Luc Schmit (JL)
Manuela Sebire (M)
Christine Segonds (C)
Valérie Sivadon-Tardy (V)
Nathalie Soismier (N)
Solen Kerneis (S)
Olivia Son (O)
Simon Sunder (S)
Florence Suy (F)
Didier Tande (D)
Jacques Tankovic (J)
Nadia Valin (N)
Nicolas Van Grunderbeeck (N)
François Vandenesch (F)
Emmanuelle Varon (E)
Renaud Verdon (R)
Michel Vergnaud (M)
Véronique Vernet-Garnier (V)
Magali Vidal (M)
Virginie Vitrat (V)
Daniel Vittecoq (D)
Fanny Vuotto (F)
None Coordination And Statistical Analyses
Isabelle Gorenne (I)
Cédric Laouenan (C)
Estelle Marcault (E)
France Mentre (F)
Blandine Pasquet (B)
Carine Roy (C)
Sarah Tubiana (S)

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Auteurs

S Tubiana (S)

Paris University, IAME, INSERM, Paris, France; Inserm Clinical Investigation Centre 1425, Paris, France. Electronic address: sarah.tubiana@aphp.fr.

E Varon (E)

National Reference Centre for Pneumococci, Centre Hospitalier Intercommunal de Créteil, Créteil, France.

C Biron (C)

Infectious Diseases Department, CHU Hôtel Dieu and INSERM UIC 1413 Nantes University, Nantes, France.

M-C Ploy (MC)

CHU Limoges, Observatoires Régionaux Du Pneumocoque, Limoges, France.

B Mourvillier (B)

Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat Hospital, Paris University, Paris, France.

M-K Taha (MK)

Institut Pasteur, Invasive Bacterial Infections Unit, National Reference Centre for Meningococci and Haemophilus Influenza, Paris, France.

M Revest (M)

Infectious Diseases and Intensive Care Unit, INSERM U 1230, CHU Rennes, Rennes University, Rennes, France.

C Poyart (C)

Department of Bacteriology, University Hospitals Paris Centre-Cochin, French National Centre for Streptococci, APHP, France.

G Martin-Blondel (G)

CHU de Toulouse, Service des Maladies Infectieuses et Tropicales, Toulouse, France; INSERM, UMR1043, Toulouse, France.

M Lecuit (M)

Institut Pasteur, Biology of Infection Unit, INSERM U1117, National Reference Centre and WHO Collaborating Center for Listeria, Paris, France; Université de Paris, Hôpital Universitaire Necker-Enfants Malades, Service des Maladies Infectieuses et Tropicales, Institut Imagine, APHP, Paris, France.

E Cua (E)

Infectious Diseases Department, CHU Nice, France.

B Pasquet (B)

Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Unité de Recherche Clinique Paris Nord, Paris, France.

M Preau (M)

GRePS, Lyon 2 University, Lyon, France.

B Hoen (B)

CHU de Nancy, Hôpitaux de Brabois, Service de Maladies Infectieuses et Tropicales, Vandœuvre-lès-Nancy, France.

X Duval (X)

Paris University, IAME, INSERM, Paris, France; Inserm Clinical Investigation Centre 1425, Paris, France; Inserm, F-CRIN, Innovative Clinical Research Network in Vaccinology (I-REIVAC), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH